Search

everythinglearnresearchcommunity

for

Search:↓

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

The model and estimator can predict drug exposure in kidney transplant patients well.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A woman's complete hair loss condition improved after recovering from COVID-19.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Oral tofacitinib successfully treated total body hair loss in one patient.

Finasteride helps female-pattern hair loss.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

The document says homoeopathic treatments are good for hair regrowth in alopecia areata but doesn't give proof.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.